Molecule Details
| InChIKey | UXZDMXYRRQJIBJ-IBGZPJMESA-N |
|---|---|
| Compound Name | Tarafenacin |
| Canonical SMILES | O=C(O[C@H]1CN2CCC1CC2)N(Cc1cc(F)c(F)c(F)c1)c1cccc(F)c1 |
| Clinical Status | Data-mined Candidate |
| Targets (Human+Pathogen) | 3 |
| Pfam Stratification | Homologous |
| Avg pChEMBL | 8.29 |
| Source | ChEMBL;BindingDB |
2D Structure
Activity Profile
DrugBank Annotations
| DrugBank ID | DB18810 |
|---|---|
| Drug Name | Tarafenacin |
| CAS Number | 385367-47-5 |
| Groups | investigational |
| ATC Codes | nan |
| Description | nan |
Cross-references: BindingDB: 50344283 CHEMBL1779046 ChemSpider: 26338489 ZINC: ZINC000003965738
Target Activities (3)
DrugBank Target Actions (1)
| Target | Gene | Target Name | Action | Type |
|---|---|---|---|---|
| P20309 | CHRM3 | Muscarinic acetylcholine receptor M3 | antagonist | targets |